AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer be distributed in the European Union. 中文版本今日新闻图件。 A AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer...
CANBERRA, June 17 (Xinhua) -- Australian Health Minister Greg Hunt said on Thursday that the Australian Technical Advisory Group on Immunisation (ATAGI) has advised that the AstraZeneca COVID-19 vaccine be administered to people aged 60 and over, rather than those aged 50 and over as was pr...
OTTAWA, April 14 (Xinhua) -- Canada on Thursday approved British drugmaker AstraZeneca's drug for the prevention of COVID-19 in immune compromised adults and children. In a statement, Health Canada said the department has determined that the drug named "Evusheld" meets Health Canada's stringe...
In a statement, AstraZeneca said the decision was made because there is now a variety of newer vaccines available that have been adapted to target COVID-19 variants. This has led to a decline in demand for the AstraZeneca vaccine, which is no longer being manufactured or supplied. Last yea...
呼应我之前的文章,柳叶刀这篇文章透露,Astrazeneca疫苗的临床试验基地,分别为英国,巴西,南非。朋友们搜索一下有关病毒新变种的消息。媒体鼓吹的所谓病毒变种,最著名的便是英国毒株,南非毒株和巴西毒株。当然,现在还要加上双突变或三突变的印度毒株,事有“凑巧”,印度大量接种的疫苗Covidshield,正是Astrazeneca的印度版...
2022 Status: AZ Mulls Scrapping Plans for U.S. Approval—Sir Menelas (Mene) Pangalos, PhD FRSB FMedSci, AstraZeneca Executive Vice-President, BioPharmaceuticals R&D, told the Financial Times on March 17 that AstraZeneca was considering not submitting its COVID-19 Vaccine to the FDA for author...
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.
Disputes over the Oxford/AstraZeneca vaccine have dominated the week, just as they have at various points over the past few months.
The COVID-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday. The vaccine, currently being evaluated by Britain's independent medicines regulator, provides "100 percent...
He said: “I don’t think this vaccine has ever been a financial driver for them. It is more a factor of being a good corporate citizen.” AstraZeneca’s status as one of the fastest-growing pharma companies in the world stemmed instead from its oncology business, Mr Mahony said. “Thi...